Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RAman For Thyroid cancER

NCT: NCT04040673 · WITHDRAWN

NCT IDNCT04040673
StatusWITHDRAWN
Start Date2024-01-31
Completion2025-01-31
SponsorGloucestershire Hospitals NHS Foundation Trust (OTHER)
First posted
Last updated

Brief Summary

Ex vivo vibrational spectroscopy (VS), including Raman spectroscopy (RS) of thyroid tissue samples, collected from patients undergoing routine diagnostic thyroid biopsies for diagnosis of potential thyroid cancer. Raman spectra are to be correlated with consensus histopathology and clinical outcomes. Multivariate analysis to be used to evaluate the classification accuracy of VS ex vivo.

Frequently Asked Questions

What is RAman For Thyroid cancER?

RAman For Thyroid cancER is a clinical trial registered under NCT04040673. Current status: WITHDRAWN.

What is the status of NCT04040673?

The current status of NCT04040673 (RAman For Thyroid cancER) is: WITHDRAWN.

When did RAman For Thyroid cancER start?

RAman For Thyroid cancER started on 2024-01-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.